Viewing Study NCT04408820


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:11 AM
Study NCT ID: NCT04408820
Status: COMPLETED
Last Update Posted: 2025-07-25
First Post: 2020-05-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module